Tim Knotnerus

Chief Executive Officer at AgomAb Therapeutics NV

Finance

Commercial Services

Profile

Tim Knotnerus is currently the Chief Executive Officer & Director at AgomAb Therapeutics NV since 2019.
Prior to this, he worked as a Senior Associate at Aescap Venture Management BV from 2008 to 2012.

Tim Knotnerus active positions

Companies	Position	Start
AgomAb Therapeutics NV AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.	Chief Executive Officer	01/01/2019

All active positions of Tim Knotnerus

Former positions of Tim Knotnerus

Companies	Position	End
Aescap Venture Management BV Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector.	Private Equity Analyst	31/05/2012

See the detail of Tim Knotnerus's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tim Knotnerus's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Aescap Venture Management BV Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector.	Finance
AgomAb Therapeutics NV AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.	Commercial Services